FDA authorizes single-dose Janssen COVID-19 vaccine

FDA Building 1 at the White Oak campus

The FDA authorized the Janssen COVID-19 vaccine Saturday for emergency use in adults 18 and older. It becomes the third vaccine available for the U.S. rollout.

The Janssen vaccine is administered in a single dose. The two previously authorized vaccines require two appointments. A single appointment could make it easier for health workers to reach patients who have difficulty returning for a second dose.

The agency will continue monitoring safety as distribution expands.

Reporting source. Cover photograph: U.S. Food and Drug Administration, public domain.